Merck & Co., Inc. filed its 13F report for Q2 2026 on August 07, 2026. The portfolio totaled 526.41 M reflecting a +50.64% change from the prior quarter, spanning 13 assets. The top 10 holdings comprised 99.8% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 2 new positions and 2 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Merck & Co submitted their Form 13F-HR for the Q2 2026 period on 08/07/2026. This was the only submission for the quarter.
In the Q2 2026 filing, Merck & Co reported a managed portfolio value of 526.41 M, consisting of 13 individual positions.
This page displays the raw filing documents. To see which stocks Merck & Co bought or sold during Q2 2026, please visit Merck & Co's Portfolio Analysis page.